Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are our donors safe?

C Viswanathan1

  • 1National Plasma Fractionation Centre, KEM Hospital, Parel, Mumbai.

Indian Journal of Pediatrics
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Ensuring blood safety involves promoting voluntary donations and rigorous screening. Advanced testing and look-back programs significantly reduce transfusion-transmitted infections, making donated blood safer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of multivariate health index for tropical seagrass meadows: a case study from Pulicat Lagoon, India.

Environmental monitoring and assessment·2026
Same author

Corn cob nanocellulose packaging for increasing the shelf life of food products.

International journal of biological macromolecules·2024
Same author

Effect of gamma-ray irradiated reduced graphene oxide (rGO) on environmental health: An in-vitro and in-vivo studies.

Environmental pollution (Barking, Essex : 1987)·2022
Same author

Electrochemical impedimetric immunosensor based on stabilized lipid bilayer-tethered WS<sub>2</sub>@MWCNT for the sensitive detection of carcinoembryonic antigen.

Mikrochimica acta·2022
Same author

Benthic foraminifera as an environmental proxy for pollutants along the coast of Chennai, India.

Chemosphere·2022
Same author

Engineering the surface of graphene oxide with bovine serum albumin for improved biocompatibility in <i>Caenorhabditis elegans</i>.

Nanoscale advances·2022
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
Same journal

A Prospective Model for Detecting Missed Appendicitis in Low-Risk Pediatric Patients: Correspondence.

Indian journal of pediatrics·2026
Same journal

Serum Periostin as a Biomarker in Pediatric Asthma: Findings from a Case-Control Study - Authors' Reply.

Indian journal of pediatrics·2026
Same journal

When the Eye Peels: An Unusual Harbinger of Kawasaki Disease - Correspondence.

Indian journal of pediatrics·2026
Same journal

Pediatric Sleep-Related Laryngospasm: Cause of Nocturnal Respiratory Distress.

Indian journal of pediatrics·2026
See all related articles

Area of Science:

  • Hematology
  • Public Health
  • Regulatory Affairs

Background:

  • Blood is regulated as a drug in India, with standards defined by the Indian Pharmacopoeia.
  • Enhancing blood safety is paramount, beginning with encouraging voluntary, non-remunerated blood donations from low-risk, regular donors.
  • Regulatory bodies have implemented measures over the past 8 years to improve blood quality and safety.

Purpose of the Study:

  • To outline the regulatory framework and quality control measures for blood safety in India.
  • To highlight the advancements in donor screening and testing for transfusion-transmitted diseases (TTD).
  • To identify the persistent challenges and strategies for ensuring a safe blood supply.

Main Methods:

  • Strengthening donor selection and deferral processes.

Related Experiment Videos

  • Implementing uniform procedures for blood collection and processing.
  • Streamlining quality control for diagnostic kits used in TTD testing.
  • Establishing look-back programs to trace recipients of blood from donors who later test positive for TTD.

    • Main Results:

    • Significant decrease in the incidence of transfusion-transmitted infections.
    • Improved safety of the blood supply through enhanced screening and testing protocols.
    • Increased adoption of modern testing methods in blood centers.
    • Emphasis on regulatory oversight and quality control of diagnostic tools.

    Conclusions:

    • Current blood safety measures, including rigorous screening and testing, have substantially reduced transfusion-transmitted infections.
    • The 'window period' remains a critical challenge, necessitating advanced strategies like look-back programs.
    • Continuous improvement in regulatory standards and donor vigilance is essential for maintaining a safe blood supply.